Highcon Systems Ltd. (TLV:HICN)

Market Cap	1.98M
Revenue (ttm)	66.20M
Net Income (ttm)	-50.24M
Shares Out	44.06M
EPS (ttm)	-2.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,079,685
Average Volume	681,125
Open	4.300
Previous Close	4.500
Day's Range	4.200 - 4.800
52-Week Range	0.045 - 177.000
Beta	0.45
RSI	20.25
Earnings Date	Aug 14, 2025

About Verve Therapeutics

Highcon Systems Ltd. engages in the provision of a proprietary technology for digital cutting and creasing solutions for post print processes in the folding carton and corrugated carton industry. Its products include Highcon Beam 2C for the digital cutting and creasing for corrugated board; Highcon Beam 2 for the digital cutting and creasing for mainstream production; Highcon Euclid 5, a digital cutting and creasing machine to suit the needs of printers working in B2/29 in format; and Highcon Euclid 5C, a digital cutting and creasing machine fo...

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• Founded: 2009
• Employees: 74
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: HICN

Financial Performance

In 2024, Highcon Systems's revenue was $18.18 million, an increase of 117.04% compared to the previous year's $8.37 million. Losses were -$13.79 million, -42.98% less than in 2023.